Back to Search

CONNER LIDDLE, MD

MD

Internal Medicine Physician

NPI: 1871344879Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

14240597-1205(UT)

Research & Publications (20)

Predicting inductive drug-drug interactions.
PMID 12605548·Pharmacogenomics·2003
6-review
Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.
PMID 12016543·Semin Liver Dis·2002
6-review
Do medical courses adequately prepare interns for safe and effective prescribing in New South Wales public hospitals?
PMID 19383059·Intern Med J·2009
4-observational
Hepatobiliary ABC transporters: physiology, regulation and implications for disease.
PMID 19482594·Front Biosci (Landmark Ed)·2009
6-review
Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice.
PMID 18388870·Clin Pharmacol Ther·2008
6-review
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.
PMID 18794066·Clin Colorectal Cancer·2008
3-trial
Transporter pumps and imatinib: a cause of pharmacokinetic resistance?
PMID 18334863·Cancer Biol Ther·2008
8-other
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
PMID 18245544·Clin Cancer Res·2008
4-observational
Look who's talking: nuclear receptors in the liver and gastrointestinal tract.
PMID 18316024·Cell Metab·2008
7-preclinical
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.
PMID 18218849·Drug Metab Dispos·2008
7-preclinical
Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.
PMID 18248309·Expert Opin Drug Metab Toxicol·2008
6-review
Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
PMID 18059400·Br J Cancer·2008
7-preclinical
Evaluation of the off-label usage of rituximab in a large teaching hospital in New South Wales.
PMID 17640190·Intern Med J·2007
8-other
Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
PMID 16844773·Proc Natl Acad Sci U S A·2006
7-preclinical
Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
PMID 17189422·Clin Cancer Res·2006
4-observational
Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites.
PMID 15671183·Proc Natl Acad Sci U S A·2005
7-preclinical
Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
PMID 15684063·Proc Natl Acad Sci U S A·2005
7-preclinical
Shielding evaluation of a medical linear accelerator vault in preparation for installing a high-dose rate 252Cf remote afterloader.
PMID 15755770·Radiat Prot Dosimetry·2005
8-other
Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform.
PMID 15992766·Biochem Biophys Res Commun·2005
8-other
Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy.
PMID 16316336·Kidney Int·2005
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
30 NORTH MARIO CAPECCHI DR, 3RD FLOOR
SALT LAKE CITY, UT 84112

Location

Practice Location

30 NORTH MARIO CAPECCHI DR, SALT LAKE CITY, UT
(801) 581-7606

Quick Facts

NPI
1871344879
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile